Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 55 years of age or older
- If joining the "Intermediate AMD Observation Arm," you must have an intermediate stage of age-related macular degeneration (AMD) in one eye
- If joining one of the "GA" study arms, you must have geographic atrophy (GA) — a form of AMD — that has not reached the very center of your vision, but does affect at least a small area near the center of the eye
Who may not be able to join:
- People whose geographic atrophy has already affected the central point of their detailed vision (the fovea)
- People whose area of geographic atrophy is larger than a certain size (17.5mm² — confirm exact measurement with trial site)
- Women who are currently pregnant
- Adults who are not able to give their own consent to participate
- People who drink heavily, specifically those who have had 5 or more episodes of binge drinking in the past month
- People whose retinal damage is caused by something other than AMD
- People who have had anti-VEGF eye injections, or who have had an active, abnormal growth of blood vessels in the study eye within the last 12 months
- People with certain other eye conditions in the study eye, including severe diabetic eye disease, blocked retinal blood vessels, a macular hole, extreme shortsightedness, eye inflammation (uveitis), or certain other conditions (confirm full list with trial site)
- People who had eye surgery in the last 90 days
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jay Stewart, MD, University of California, San Francisco
Phone: (628) 206-3123
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Geographic atrophy progression rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.